Atrion Corp
NASDAQ:ATRI
Intrinsic Value
Atrion Corp. engages in the manufacture and development of products for medical applications. [ Read More ]
The intrinsic value of one ATRI stock under the Base Case scenario is 297.21 USD. Compared to the current market price of 414.95 USD, Atrion Corp is Overvalued by 28%.
Valuation Backtest
Atrion Corp
Run backtest to discover the historical profit from buying and selling ATRI stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Atrion Corp
Current Assets | 114.8m |
Cash & Short-Term Investments | 6.3m |
Receivables | 23m |
Other Current Assets | 85.5m |
Non-Current Assets | 146.1m |
Long-Term Investments | 8.2m |
PP&E | 125.3m |
Intangibles | 10.8m |
Other Non-Current Assets | 1.7m |
Current Liabilities | 12.6m |
Accounts Payable | 6.6m |
Accrued Liabilities | 5.9m |
Other Current Liabilities | 106k |
Non-Current Liabilities | 5.3m |
Other Non-Current Liabilities | 5.3m |
Earnings Waterfall
Atrion Corp
Revenue
|
169.3m
USD
|
Cost of Revenue
|
-106.9m
USD
|
Gross Profit
|
62.4m
USD
|
Operating Expenses
|
-39.8m
USD
|
Operating Income
|
22.6m
USD
|
Other Expenses
|
-3.2m
USD
|
Net Income
|
19.4m
USD
|
Free Cash Flow Analysis
Atrion Corp
ATRI Profitability Score
Profitability Due Diligence
Atrion Corp's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
Score
Atrion Corp's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
ATRI Solvency Score
Solvency Due Diligence
Atrion Corp's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Score
Atrion Corp's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ATRI Price Targets Summary
Atrion Corp
According to Wall Street analysts, the average 1-year price target for ATRI is 300 USD .
Ownership
ATRI Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
ATRI Price
Atrion Corp
Average Annual Return | -8.53% |
Standard Deviation of Annual Returns | 11.89% |
Max Drawdown | -67% |
Market Capitalization | 730.3m USD |
Shares Outstanding | 1 759 840 |
Percentage of Shares Shorted | 12.55% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Atrion Corp. engages in the manufacture and development of products for medical applications. The company is headquartered in Allen, Texas and currently employs 667 full-time employees. The firm's medical products primarily serve the fluid delivery, cardiovascular and ophthalmology markets. The company has developed a variety of valves designed to fill, hold and release controlled amounts of fluids or gasses on demand for use in various intubation, intravenous, catheter and other applications in fields, such as anesthesia and oncology. The firm's cardiovascular product, Myocardial Protection System (MPS3), is a technology used in open-heart surgery that delivers fluids and medications, mixes critical drugs, and controls temperature and pressure. Its ophthalmic products include specialized medical devices that disinfect contact lenses. The company also manufactures a line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults. Its medical and non-medical products are manufactured at facilities in Florida, Alabama and Texas.
Contact
IPO
Employees
Officers
The intrinsic value of one ATRI stock under the Base Case scenario is 297.21 USD.
Compared to the current market price of 414.95 USD, Atrion Corp is Overvalued by 28%.